TNYA vs. ICCM

In the year-to-date period, TNYA achieves a -67.83% return, which is significantly lower than ICCM's -4.55% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Tenaya Therapeutics, Inc. (TNYA) and Icecure Medical (ICCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TNYA Sharpe Ratio is -0.70, which is lower than the ICCM Sharpe Ratio of -0.01. The chart below compares the historical Sharpe Ratios of TNYA and ICCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither TNYA nor ICCM has paid dividends to shareholders.

The maximum TNYA drawdown since its inception was -98.69%, roughly equal to the maximum ICCM drawdown of -95.33%. Use the drawdown chart below to compare losses from any high point for TNYA and ICCM.

Tenaya Therapeutics, Inc. (TNYA) has a higher volatility of 23.43% compared to Icecure Medical (ICCM) at 21.24%. This indicates that TNYA's price experiences larger fluctuations and is considered to be riskier than ICCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Tenaya Therapeutics, Inc. and Icecure Medical. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.